Indeed, clinical evidence already exists for this pathway regulating skeletal muscle via ActRIIB-Fc treatment in the form of ACE-031, which has been shown to increase total lean body mass and thigh muscle volume in patients with muscular dystrophy [16]. The gene discussed is ACVR2B; the disease is muscular dystrophy.